Disease, Disability and Injury Prevention and Control Special Emphasis Panel: Optimizing Strategies to Provide Sexually Transmitted Disease (STD) Partner Services, PA# 00080.

---
identifier: "/us/fr/00-16722"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability and Injury Prevention and Control Special Emphasis Panel: Optimizing Strategies to Provide Sexually Transmitted Disease (STD) Partner Services, PA# 00080."
title_number: 0
title_name: "Federal Register"
section_number: "00-16722"
section_name: "Disease, Disability and Injury Prevention and Control Special Emphasis Panel: Optimizing Strategies to Provide Sexually Transmitted Disease (STD) Partner Services, PA# 00080."
positive_law: false
currency: "2000-07-03"
last_updated: "2000-07-03"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "00-16722"
document_type: "notice"
publication_date: "2000-07-03"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "65 FR 41079"
fr_volume: 65
---


#  Disease, Disability and Injury Prevention and Control Special Emphasis Panel: Optimizing Strategies to Provide Sexually Transmitted Disease (STD) Partner Services, PA# 00080.

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting.

*Name:* Disease, Disability and Injury Prevention and Control Special Emphasis Panel: Optimizing Strategies to Provide Sexually Transmitted Disease (STD) Partner Services, PA# 00080.

*Times and Dates:* 8:30 a.m-9 a.m., August 29, 2000 (Open), 9 a.m.-4:30 p.m., August 29, 2000 (Closed), 8:30 a.m.-4:30 p.m., August 30, 2000 (Closed).

*Place:* Centers for Disease Control and Prevention, 12 Corporate Square Boulevard, Building 12, Conference Rooms 1203 and 1307, Atlanta, GA 30329.

*Status:* Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Associate Director for Management and Operations, CDC, pursuant to Public Law 92-463.

*Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to Program Announcement 00080.

*Contact Person for more Information:* Beth Wolfe, Prevention Support Office, National Center for HIV, STD, and TB Prevention, CDC, Corporate Square Office Park, 11 Corporate Square Boulevard, M/S E07, Atlanta, Georgia 30329, telephone 404/639-8025, e-mail [email protected].

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: June 23, 2000.

Carolyn J. Russell,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).